Join Us in Boston for Discovery On Target 2023!

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses and a training seminar, interactive group discussions, and networking options that help you engage with experts and solutions providers.

Our 20th Anniversary event brings back popular topics like immunomodulation, protein degraders, and RNA, plus new, expanded, or returning programming on transcription factors, small molecules for cancer targets, and kinases.

A Visual Walkthrough of Discovery On Target 2022

2022 Image Gallery
2022 Video Highlights

2023 Premier Sponsors

View All Sponsors

2022 Plenary Keynote Program

James A. Wells Photo

Pirating Biology to Detect and Degrade Extracellular Proteins
James A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco

Anabella Villalobos

Therapeutic Modalities for Neuroscience Diseases
Anabella Villalobos, PhD, Senior Vice President, Biotherapeutics & Medicinal Sciences, Biogen


Register with Confidence

In Person Attendance Video
Virtual Acesss Video

Flexible Registration – Seamlessly switch between In-Person and/or Virtual

Select an in-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Our flexible registration is designed to take the uncertainties out of these uncertain times.

Registration Options